Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 3,925B 585B P/E ratio 2024 *
38.9x
P/E ratio 2025 * 30.6x
Enterprise value 3,929B 585B EV / Sales 2024 *
13.5x
EV / Sales 2025 * 11.2x
Free-Float
70.25%
Yield 2024 *
1.29%
Yield 2025 * 1.7%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.30%
1 week-4.01%
Current month-5.64%
1 month+4.30%
3 months-5.45%
6 months+3.53%
Current year+26.80%
More quotes
1 week
879.80
Extreme 879.8
942.40
1 month
820.00
Extreme 820
942.40
Current year
688.80
Extreme 688.8
1 033.20
1 year
614.30
Extreme 614.3
1 033.20
3 years
302.20
Extreme 302.2
1 033.20
5 years
164.35
Extreme 164.35
1 033.20
10 years
109.10
Extreme 109.1
1 033.20
More quotes
Director TitleAgeSince
Chief Executive Officer 58 90-12-31
Director of Finance/CFO 53 98-12-31
Chief Tech/Sci/R&D Officer - 15-09-30
Manager TitleAgeSince
Director/Board Member 62 15-03-18
Director/Board Member 59 17-03-22
Chairman 62 17-03-22
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.36%-4.01%+33.76%+181.19%583B
-3.55%-2.92%+63.52%+251.69%822B
-1.42%+0.46%+2.68%-5.74%397B
-2.11%-1.19%+32.01%+72.78%341B
+2.41%+0.96%+10.31%+53.49%301B
+0.12%-5.53%+16.80%+47.37%256B
-0.78%-3.22%+8.78%-24.28%262B
-1.21%-2.95%+12.67%+18.64%236B
-1.90%-2.01%+27.70%+43.29%174B
+0.42%-0.73%-19.42%-39.13%162B
Average -0.28%-2.11%+18.88%+59.93% 353.35B
Weighted average by Cap. -0.27%-2.29%+27.80%+102.57%
See all sector performances
2024 *2025 *
Net sales 290B 43.23B 349B 52B
Net income 102B 15.17B 128B 19.05B
Net Debt 4.63B 690M -17.33B -2.58B
More financial data * Estimated data
Logo Novo Nordisk A/S
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Employees
69,260
Calendar
More about the company
Date Price Change Volume
24-09-06 878.00 kr -0.81% 129,320
24-09-05 885.20 kr -2.16% 2,343,150
24-09-04 904.70 kr -2.45% 1,873,627
24-09-03 927.40 kr -0.18% 1,809,305
24-09-02 929.10 kr -0.96% 1,275,996

Delayed Quote Nasdaq Copenhagen, September 05, 2024 at 11:20 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
885.20DKK
Average target price
969.52DKK
Spread / Average Target
+9.53%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW